Simplified Chinese
English
描述
Revolutionizing Life Science through Precision Sequencing and Multi-Omics Solutions
What is Multi-Omics？
Multi-omics provides a comprehensive perspective that helps us to continuously explore and discover new findings across multiple levels of biology. This biological analysis method combines genomic data with transcriptomics, epigenetics, proteomics and other data modes, enabling the measurement of gene expression, gene activation, and protein levels. Multi-omics analysis studies can help us to gain a more comprehensive understanding of the impact of molecular changes on normal development, cell response, and disease. Researchers can use multi-omics techniques to better link genotypes with phenotypes, and continuously explore and discover new drug targets and biomarkers.
Services
  • The pan-cancer comprehensive mutation analysis platform covers key guidelines and relevant genes and molecular features in clinical trials, and is applicable to solid tumors and hematological tumors. It can detect molecular features such as point mutations, insertion-deletion variations, copy number variations, fusion genes, etc.
    Solutions for Cancer Targeted Therapy
    The pan-cancer comprehensive mutation analysis platform covers key guidelines and relevant genes and molecular features in clinical trials, and is applicable to solid tumors and hematological tumors. It can detect molecular features such as point mutations, insertion-deletion variations, copy number variations, fusion genes, etc.
  • Immune checkpoint inhibitors are the most mature and widely used treatment option in clinical research for tumor immunity. The tumor-related immune checkpoint molecules mainly include PD-L1, CTLA4, and others. Clinical studies of multiple PD-1/PD-L1 inhibitors at home and abroad have shown that the efficacy of immune checkpoint inhibitors is related to biomarkers such as PD-L1 expression, TMB, and MSI.
    Immuno-oncology therapy development
    Immune checkpoint inhibitors are the most mature and widely used treatment option in clinical research for tumor immunity. The tumor-related immune checkpoint molecules mainly include PD-L1, CTLA4, and others. Clinical studies of multiple PD-1/PD-L1 inhibitors at home and abroad have shown that the efficacy of immune checkpoint inhibitors is related to biomarkers such as PD-L1 expression, TMB, and MSI.
  • The testing solutions and customized services we provide comply with the requirements of drug NDA/IND application and clinical trial quality standards. We have collaborated with leading partners in the industry to complete multiple NDA/IND applications, clinical trial projects, and thousands of clinical sample tests.
    Cell and Gene Therapy
    The testing solutions and customized services we provide comply with the requirements of drug NDA/IND application and clinical trial quality standards. We have collaborated with leading partners in the industry to complete multiple NDA/IND applications, clinical trial projects, and thousands of clinical sample tests.
  • Provide professional interpretation of medical genetics based on the latest scientific evidence, combined with independently developed and validated interpretation analysis software and validation analysis process, improve the accuracy of variant interpretation rating in medical interpretation, and provide comprehensive, precise and scientific assistance and guidance for molecular diagnosis of diseases.
    Solutions for Genetic Disorder
    Provide professional interpretation of medical genetics based on the latest scientific evidence, combined with independently developed and validated interpretation analysis software and validation analysis process, improve the accuracy of variant interpretation rating in medical interpretation, and provide comprehensive, precise and scientific assistance and guidance for molecular diagnosis of diseases.
  • Cell and animal models are valuable tools for humans to clarify the development goals of drugs and treatments and to help strengthen understanding of disease mechanisms. Xinzenda provides precise, efficient, and high-throughput testing solutions for preclinical drug research using cell and animal models. Through multidimensional exploration of drug targets, study of drug efficacy and immune response mechanisms, high-throughput assisted drug screening, and enhanced quality control of experimental and production processes, we help achieve more precise and efficient innovative drug development.
    Solutions for PDX models
    Cell and animal models are valuable tools for humans to clarify the development goals of drugs and treatments and to help strengthen understanding of disease mechanisms. Xinzenda provides precise, efficient, and high-throughput testing solutions for preclinical drug research using cell and animal models. Through multidimensional exploration of drug targets, study of drug efficacy and immune response mechanisms, high-throughput assisted drug screening, and enhanced quality control of experimental and production processes, we help achieve more precise and efficient innovative drug development.
  • We need a novel and effective vaccine development strategy, utilizing multi-omics technologies such as genomics, transcriptomics, and proteomics to facilitate innovative drug research and development. As a comprehensive platform, we can provide solutions for metagenomic sequencing, blood plasma biomarker screening, and immune analysis to assist pharmaceutical companies in accelerating vaccine development.
    Solutions for Vaccine
    We need a novel and effective vaccine development strategy, utilizing multi-omics technologies such as genomics, transcriptomics, and proteomics to facilitate innovative drug research and development. As a comprehensive platform, we can provide solutions for metagenomic sequencing, blood plasma biomarker screening, and immune analysis to assist pharmaceutical companies in accelerating vaccine development.
Contact us
240 Hedan Road, Waigaoqiao Pilot Free Trade Zone, Shanghai, China
Shanghai International Biomedical Science & Innovation Center info@sequanta.com
021-20500599
Copyright: Shanghai Sequanta Technologies Co., Ltd. Record No.: Shanghai
ICP Record No. 2021028059-1